COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
IconOVir Bio is a preclinical biotech developing tumor-selective, intravenously deliverable oncolytic virus therapies via a proprietary Salk Institute–based platform, advancing multiple candidates including IOV-1042 across solid tumor types.
